BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Jimenez-Tellez N, Greenway SC. Cellular models for human cardiomyopathy: What is the best option? World J Cardiol 2019; 11(10): 221-235 [PMID: 31754410 DOI: 10.4330/wjc.v11.i10.221]
URL: https://www.wjgnet.com/1948-0210/full/v11/i10/221.htm
Number Citing Articles
1
Ilaria Gisone, Antonella Cecchettini, Elisa Ceccherini, Elisa Persiani, Maria Aurora Morales, Federico Vozzi. Cardiac tissue engineering: Multiple approaches and potential applicationsFrontiers in Bioengineering and Biotechnology 2022; 10 doi: 10.3389/fbioe.2022.980393
2
Jinjuan Yang, Shaoxiang Chen, Fuyu Duan, Xiuxiu Wang, Xiaoxian Zhang, Boonxuan Lian, Meng Kou, Zhixin Chiang, Ziyue Li, Qizhou Lian. Mitochondrial Cardiomyopathy: Molecular Epidemiology, Diagnosis, Models, and Therapeutic ManagementCells 2022; 11(21): 3511 doi: 10.3390/cells11213511
3
Saeideh Edalati, Safoura Khajeniazi. Positive effect of Periostin on repair of Isopreternol induced ischemic damaged cardiomyocyte: an in vitro modelRegenerative Therapy 2022; 20: 26 doi: 10.1016/j.reth.2022.03.003
4
Melania Lippi, Ilaria Stadiotti, Giulio Pompilio, Elena Sommariva. Human Cell Modeling for Cardiovascular DiseasesInternational Journal of Molecular Sciences 2020; 21(17): 6388 doi: 10.3390/ijms21176388
5
M.I. Nasser, Xiao Qi, Shuoji Zhu, Yin He, Mingyi Zhao, Huiming Guo, Ping Zhu. Current situation and future of stem cells in cardiovascular medicineBiomedicine & Pharmacotherapy 2020; 132: 110813 doi: 10.1016/j.biopha.2020.110813
6
Esmeralda Alonso-Barroso, Belén Pérez, Lourdes Ruiz Desviat, Eva Richard. Cardiomyocytes Derived from Induced Pluripotent Stem Cells as a Disease Model for Propionic AcidemiaInternational Journal of Molecular Sciences 2021; 22(3): 1161 doi: 10.3390/ijms22031161
7
Mohamed M. Bekhite, P. Christian Schulze. Human Induced Pluripotent Stem Cell as a Disease Modeling and Drug Development Platform—A Cardiac PerspectiveCells 2021; 10(12): 3483 doi: 10.3390/cells10123483
8
Takahiro Iwamiya, Bertrand-David Segard, Yuimi Matsuoka, Tomomi Imamura, Vincenzo Lionetti. Human cardiac fibroblasts expressing VCAM1 improve heart function in postinfarct heart failure rat models by stimulating lymphangiogenesisPLOS ONE 2020; 15(9): e0237810 doi: 10.1371/journal.pone.0237810
9
Rafael Dariolli, Chiara Campana, Amy Gutierrez, Eric A. Sobie. In vitro and In silico Models to Study SARS-CoV-2 Infection: Integrating Experimental and Computational Tools to Mimic “COVID-19 Cardiomyocyte”Frontiers in Physiology 2021; 12 doi: 10.3389/fphys.2021.624185
10
Keyang Zhu, Xiaoming Bao, Yingchao Wang, Ting Lu, Ling Zhang. Human induced pluripotent stem cell (hiPSC)-derived cardiomyocyte modelling of cardiovascular diseases for natural compound discoveryBiomedicine & Pharmacotherapy 2023; 157: 113970 doi: 10.1016/j.biopha.2022.113970
11
Adéla Krajčová, Vlasta Němcová, Milada Halačová, Petr Waldauf, Martin Balík, František Duška. Amiodarone but not propafenone impairs bioenergetics and autophagy of human myocardial cellsToxicology and Applied Pharmacology 2023; 477: 116676 doi: 10.1016/j.taap.2023.116676
12
Nazanin Vaziri, Diogo Marques, Steven C. Greenway, Chad A. Bousman. The cellular mechanism of antipsychotic-induced myocarditis: A systematic reviewSchizophrenia Research 2023; 261: 206 doi: 10.1016/j.schres.2023.09.039
13
Magali Seguret, Eva Vermersch, Charlène Jouve, Jean-Sébastien Hulot. Cardiac Organoids to Model and Heal Heart Failure and CardiomyopathiesBiomedicines 2021; 9(5): 563 doi: 10.3390/biomedicines9050563
14
Cátia D. Correia, Anita Ferreira, Mónica T. Fernandes, Bárbara M. Silva, Filipa Esteves, Helena S. Leitão, José Bragança, Sofia M. Calado. Human Stem Cells for Cardiac Disease Modeling and Preclinical and Clinical Applications—Are We on the Road to Success?Cells 2023; 12(13): 1727 doi: 10.3390/cells12131727